3Gomez-Garre D, Munoz-Paeheco P, Gonzalez-Rubio ML, et al. Ezetimibe reduces plaque inflammation in a rabbit model of athero- sclerosis and inhibits monocyte migration in addition to its lipid- lowering effect [ J ]iBr J Pharmacol, 2009,156 ( 8 ) : 1218 -1227.
4Ghiadoni L, Taddei S, Virdis A, et al. Endothelial function and common carotid artery wall thickening in patients with essential hypertension[J]. Hypertension, 1998,32( 1 ) :25-32.
5Held C, Hjemdahl P, Eriksson SV, et al. Prognostic implications of intima-media thickness and plaques inthe carotid and femoral arteries in patients with. stable angina pectoris [ J ]. Eur Heart J, 2001,22( 1 ) :62-72.
6Jander S, Sitzer M, Wendt A, et al. Expression of tissue factor in highgrade carotid artery stenosis association with plaque destabili- zation [ J]. Stroke,2001,32 (4) :850-854.
7Natarajan P, Ray KK, Cannon CP. High-density lipoprotein and coronary heart disease :current and future therapies[ J]. J Am Coil Cardiol. 2010.55 ( 13 ) 1283-1299.
8Hu M, Mak VW,Tomlinson B. Intmnie variants in SLCO1 B1 relat- ed to statin-induced myopathy are associated with the low-density lipopmtein cholesterol response to statins in Chinese patients with hyperlipidaemia [ J ]. Pharmacogenet Genomics, 2012, 22 ( ll ) : 803 -806.
9Xie P,Jia L, Ma Y, st al. Ezetimibe inhibits hepatic Niemann-Pick CI-Like 1 to facilitate macmphage reverse cholesterol transport in mice[ J]. Arterioscler Thromb Vasc Biol,2013,33 (5) :920-925.
10Davis HR Jr, Lowe RS, Neff DR. Effects of ezetimibe on athemscle- rosis in preclinical models [ J ]. Atherosclemsis, 2011,215 ( 2 ) : 255-278.
